Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 22 Other solid neoplasm 2 Tumor-Agnostic 1 Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 7 pembrolizumab 6 olaparib 5 Carboplatin 4 Bevacizumab 4 tisotumab vedotin 2 niraparib 2 mirvetuximab soravtansine 2 durvalumab 2 defactinib 2 Topotecan 2 Taxes 2 Saline Solution 2 Immunoglobulin G 2 Disulfides 2 Cisplatin 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 sodium thiosulfate 1 sapanisertib 1 sacituzumab govitecan 1 rucaparib 1 relatlimab 1 relacorilant 1 pertuzumab 1 palbociclib 1 osimertinib 1 omipalisib 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Pemetrexed × Gynecologic × Clear all

NCT04697628 2026-02-24

innovaTV 301

Seagen Inc.

Phase 3 Completed

502 enrolled 18 charts 1 FDA

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡